Your browser doesn't support javascript.
loading
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Liu, Enchi; Luthman, Johan; Cedarbaum, Jesse M; Schmidt, Mark E; Cole, Patricia E; Hendrix, James; Carrillo, Maria C; Jones-Davis, Dorothy; Tarver, Erika; Novak, Gerald; De Santi, Susan; Soares, Holly D; Potter, William Z; Siemers, Eric; Schwarz, Adam J.
Affiliation
  • Liu E; Neuroscience Biomarkers, Discovery, Janssen Research and Development, San Diego, CA, USA. Electronic address: eliu12@its.jnj.com.
  • Luthman J; Neuroscience Clinical Development, Clinical Neuroscience Eisai, Woodcliff Lake, NJ, USA.
  • Cedarbaum JM; Clinical Development, Biogen, Cambridge, MA, USA.
  • Schmidt ME; Experimental Medicine, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Cole PE; Clinical and Translational Science, Imaging, Takeda Pharmaceuticals, Inc, Deerfield, IL, USA.
  • Hendrix J; Medical and Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Carrillo MC; Medical and Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Jones-Davis D; Foundation for the NIH, Bethesda, MD, USA.
  • Tarver E; Foundation for the NIH, Bethesda, MD, USA.
  • Novak G; Neuroscience Clinical Development, Janssen Research and Development, Titusville, NJ, USA.
  • De Santi S; Medical Affairs, Piramal Pharma Inc, Boston, MA, USA.
  • Soares HD; Clinical Biomarkers, Bristol-Meyer Squibb, Hopewell, NJ, USA.
  • Potter WZ; Office of the Director, National Institute of Mental Health, Rockville, MD, USA.
  • Siemers E; Biomedicines Business Unit, Alzheimer's Disease Platform Team, Eli Lilly and Company, Indianapolis, IN, USA.
  • Schwarz AJ; Tailored Therapeutics, Eli Lilly and company, Indianapolis, IN, USA.
Alzheimers Dement ; 11(7): 840-9, 2015 Jul.
Article in En | MEDLINE | ID: mdl-26194317
ABSTRACT
The Alzheimer's Disease Neuroimaging Initiative (ADNI) Private Partner Scientific Board (PPSB) is comprised of representatives of private, for-profit entities (including pharmaceutical, biotechnology, diagnostics, imaging companies, and imaging contract research organizations), and nonprofit organizations that provide financial and scientific support to ADNI through the Foundation for the National Institutes of Health. The PPSB serves as an independent, open, and precompetitive forum in which all private sector and not-for-profit partners in ADNI can collaborate, share information, and offer scientific and private-sector perspectives and expertise on issues relating to the ADNI project. In this article, we review and highlight the role, activities, and contributions of the PPSB within the ADNI project, and provide a perspective on remaining unmet needs and future directions.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Consultants / Public-Private Sector Partnerships / Alzheimer Disease / Neuroimaging Type of study: Etiology_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Alzheimers Dement Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Consultants / Public-Private Sector Partnerships / Alzheimer Disease / Neuroimaging Type of study: Etiology_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Alzheimers Dement Year: 2015 Document type: Article